HPV-vaccination til kvinder

Lisa Maria Bæk Høgh; Dina Overgaard Eriksen; Ina Marie Dueholm Hjorth; Anne Hammer

HPV-vaccination til kvinder

Lisa Maria Bæk Høgh^*, Dina Overgaard Eriksen, Ina Marie Dueholm Hjorth, Anne Hammer

^*Kontaktforfatter

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

13 Downloads (Pure)

Abstract

HPV vaccination is associated with a reduced risk of cervical cancer and its precursors, with greatest protection when the vaccine is administered before sexual debut. This review aims to discuss whether immunization with the nonavalent HPV vaccine should be recommended to women who have previously been vaccinated with the bi- or quadrivalent HPV vaccine and to women who have previously undergone treatment for condylomas or dysplasia of the vulva, vagina, or cervix.

Bidragets oversatte titel	HPV vaccination for women
Originalsprog	Dansk
Artikelnummer	V11210891
Tidsskrift	Ugeskrift for Læger
Vol/bind	184
Udgave nummer	22
Sider (fra-til)	2143-2145
Antal sider	3
ISSN	0041-5782
Status	Udgivet - 23 maj 2022

Emneord

Female
Humans
Papillomavirus Infections
Papillomavirus Vaccines
Sexual Behavior
Uterine Cervical Neoplasms
Vaccination
prevention & control

Adgang til dokumentet

Høgh et al. (2022). HPV-vaccination til kvinderForlagets udgivne version, 350 KBLicens: CC BY-NC-ND 4.0

https://ugeskriftet-dk.auh.aub.aau.dk/videnskab/hpv-vaccination-til-kvinderLicens: CC BY-NC-ND 4.0

AUB Link

Søg efter materialet i Aalborg Universitetsbiblioteks søgemaskine

Citationsformater

@article{54a66d563c744efc986c1d8e534bcfeb,

title = "HPV-vaccination til kvinder",

abstract = "HPV vaccination is associated with a reduced risk of cervical cancer and its precursors, with greatest protection when the vaccine is administered before sexual debut. This review aims to discuss whether immunization with the nonavalent HPV vaccine should be recommended to women who have previously been vaccinated with the bi- or quadrivalent HPV vaccine and to women who have previously undergone treatment for condylomas or dysplasia of the vulva, vagina, or cervix.",

keywords = "Female, Humans, Papillomavirus Infections, Papillomavirus Vaccines, Sexual Behavior, Uterine Cervical Neoplasms, Vaccination, prevention & control",

author = "H{\o}gh, {Lisa Maria B{\ae}k} and Eriksen, {Dina Overgaard} and Hjorth, {Ina Marie Dueholm} and Anne Hammer",

year = "2022",

month = may,

day = "23",

language = "Dansk",

volume = "184",

pages = "2143--2145",

journal = "Ugeskrift for L{\ae}ger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "22",

}

TY - JOUR

T1 - HPV-vaccination til kvinder

AU - Høgh, Lisa Maria Bæk

AU - Eriksen, Dina Overgaard

AU - Hjorth, Ina Marie Dueholm

AU - Hammer, Anne

PY - 2022/5/23

Y1 - 2022/5/23

N2 - HPV vaccination is associated with a reduced risk of cervical cancer and its precursors, with greatest protection when the vaccine is administered before sexual debut. This review aims to discuss whether immunization with the nonavalent HPV vaccine should be recommended to women who have previously been vaccinated with the bi- or quadrivalent HPV vaccine and to women who have previously undergone treatment for condylomas or dysplasia of the vulva, vagina, or cervix.

AB - HPV vaccination is associated with a reduced risk of cervical cancer and its precursors, with greatest protection when the vaccine is administered before sexual debut. This review aims to discuss whether immunization with the nonavalent HPV vaccine should be recommended to women who have previously been vaccinated with the bi- or quadrivalent HPV vaccine and to women who have previously undergone treatment for condylomas or dysplasia of the vulva, vagina, or cervix.

KW - Female

KW - Humans

KW - Papillomavirus Infections

KW - Papillomavirus Vaccines

KW - Sexual Behavior

KW - Uterine Cervical Neoplasms

KW - Vaccination

KW - prevention & control

M3 - Tidsskriftartikel

C2 - 35656616

SN - 0041-5782

VL - 184

SP - 2143

EP - 2145

JO - Ugeskrift for Læger

JF - Ugeskrift for Læger

IS - 22

M1 - V11210891

ER -

HPV-vaccination til kvinder

Abstract

Emneord

Adgang til dokumentet

AUB Link

Fingeraftryk

Citationsformater